Connect with us

Fitness

Xponential Fitness, Inc. (XPOF) Q2 2024 Earnings Call Transcript

Published

on

Xponential Fitness, Inc. (XPOF) Q2 2024 Earnings Call Transcript

Xponential Fitness, Inc. (NYSE:XPOF) Q2 2024 Earnings Conference Call August 1, 2024 4:30 PM ET

Company Participants

Avery Wannemacher – Senior Associate, ADDO IR
Brenda Morris – Lead Director
Mark King – Chief Executive Officer
Sarah Luna – President
John Meloun – Chief Financial Officer

Conference Call Participants

Randal Konik – Jefferies
John Heinbockel – Guggenheim Partners
Ryan Meyers – Lake Street Capital Markets
Korinne Wolfmeyer – Piper Sandler
Chris O’Cull – Stifel Financial Corp.
Jonathan Komp – Robert W. Baird & Co.
Warren Cheng – Evercore ISI
Joseph Altobello – Raymond James
Jeff Van Sinderen – B. Riley Financial
George Kelly – ROTH Capital Partners

Operator

Greetings and welcome to the Xponential Fitness, Inc. Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator instructions] As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Avery Wannemacher, Investor Relations. Thank you. You may begin.

Avery Wannemacher

Thank you, operator. Good afternoon and thank you all for joining our conference call to discuss Xponential Fitness second quarter 2024 financial results. I am joined by Brenda Morris, Lead Director; Mark King, Chief Executive Officer; and John Meloun, Chief Financial Officer. Sarah Luna, President, will join Mark and John for the question-and-answer portion of the call.

A recording of this call will be posted on the Investors section of our website at investor.xponential.com. We remind you that during this conference call, we will make certain forward-looking statements, including discussions of our business outlook and financial projections. These forward-looking statements are based on management’s current expectations and involve risks and uncertainties that could cause our actual results to differ materially from such expectations. For a more detailed description of these risks and uncertainties, please refer to

Continue Reading